banner

BIOSPACE (PRESS RELEASE) (BLOG)

  • email
  • twitter
  • linkedin
  • facebook
UPDATE: Bomb Threat Forces Evacuation of AstraZeneca COVID-19 Vaccine Manufacturing Plant
A bomb squad was called to a facility in the United Kingdom where doses of AstraZeneca’s COVID-19 vaccine are manufactured. For a brief time...

2019 FDA Warning Letters in the BioPharma Industry so Far
As 2019 enters its second half, BioSpace takes a look at some of the warning letters issued by the U.S. Food and Drug Administration to the...

Lonza Snaps up Drug Production Facility From Novartis
Swiss pharma and chemical company Lonza announced this morning that it will acquire a sterile drug product fill & finish facility from Novartis....

CherryCircle Software Unveils Enhanced QbDVision® Platform to Transform Pharma Product Life Cycle
AUSTIN, Texas — June 18, 2019 — CherryCircle Software, the company providing the QbDVision® platform to accelerate the development of...

Manufacturing Issues Deliver More Delays for Novavax's COVID-19 Vaccine
rafapress/Shutterstock Gaithersburg, Maryland - based Novavax is reportedly having problems getting its COVID-19 vaccine to the finish line....

FUJIFILM Diosynth to Expand Manufacturing Capabilities With $850 Million Infusion
VCG/VCG via Getty Images With an $850 million investment from parent company FUJIFILM Corporation,FUJIFILM Diosynth Biotechnologies is expanding...

Pfizer-BioNTech Vaccine Effective Long-Term in Teens; US Vaccine Data in 2076?
News on COVID-19 vaccine developments and disease studies continue to deliver highs and lows. Here are some of the more recent...

Judge: FDA Cannot Have Until 2076 to Disclose Pfizer/BioNTech Vaccine Data
A U.S. federal judge in Texas has denied attempts by the U.S. Food and Drug Administration (FDA) to conceal data on Pfizer’s COVID-19 vaccine....

Ocugen Ends Week on Low as FDA Rejects Covaxin EUA for Kids
The U.S. Food and Drug Administration turned down Ocugen’s Emergency Use Authorization (EUA) request for Covaxin in children 2 to 18 years....

FDA Commissioner Califf and the Potential of RWE in Clinical Trials
When Robert Califf became the new commissioner of the U.S. Food & Drug Administration, he did so with a plan to emphasize the use of real-world...